<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-30T12:23:05Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-8583.000025">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-8583.000025</identifier>
									<datestamp>2017-08-24</datestamp>
									<setSpec>PTZ.GJODMS:VOL4</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Obese chronic kidney disease diabetic’s patients: Malignant tumours
										</dc:title><dc:creator>Esparza Martín N</dc:creator><dc:creator> Suria González S</dc:creator><dc:creator> Bosch Benítez-Parodi E</dc:creator><dc:creator> Guerra Rodríguez R</dc:creator><dc:creator> Ramírez Puga A</dc:creator><dc:creator> Batista García F</dc:creator><dc:creator>García Cantón C</dc:creator><dc:description>&lt;p&gt;Patients with chronic kidney disease (CKD) have a high incidence of malignant tumours. Purpose of the study: Prospective observational study of factors present at initial evaluation of stage 3 CKD patients proceeding from external consultations after two years of follow-up. Exclusion criteria: Under 40 or mayor 79 years old, anaemia, previous heart or hepatic failure, valvular or isquemic cardiopathy, arrhythmias, clinical arterial peripheral disease or immunosuppressive treatment. Inclusion criteria: All the incidental patients who wish to participated between January, 2012 and January, 2014. The study was approved by the Committee of Ethics of Clinical Investigation.&lt;/p&gt;</dc:description>
										<dc:publisher>Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications</dc:publisher>
										<dc:date>2017-08-24</dc:date>
										<dc:type>Letter to Editor</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-8583.000025</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Esparza Martín N et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
